Matthew Esteban Mantilla

Matthew Mantilla practices at Coastal Pulmonary in Wilmington, North Carolina.

Matthew Mantilla's NPI, 1235745605, was assigned on September 21, 2020. Matthew Mantilla holds North Carolina license 0010-13280.

Matthew Mantilla's primary practice is Coastal Pulmonary, at 1090 Medical Center Dr, Wilmington, NC 28401 in New Hanover County. The practice phone is (910) 343-3345.

Matthew Mantilla's primary practice is Coastal Pulmonary in Wilmington, North Carolina. Matthew Mantilla is also affiliated with Novant Health New Hanover Regional Medical Center. The medical group on file is Novant Health Heart & Vascular Institute, Wilmington Main. Dmand AI also links Matthew Mantilla to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Mantilla practices, 4 sites in all. Vendor and product names are available with a free account.

Physician assistant is Matthew Mantilla's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Matthew Mantilla is licensed in North Carolina.

Dmand AI lists arthritis, asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, hypersomnia, pneumonia and pulmonary fibrosis among the conditions Matthew Mantilla treats.

CMS data shows 430 Medicare services from Matthew Mantilla across 8 procedure codes in 2024, for 256 Medicare patients. Medicare paid $28,540 for them. Every service was in an office.

CMS counts 256 Medicare patients who saw Matthew Mantilla in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Matthew Mantilla's median patient age at 65, with 51% women.

In 2024, Matthew Mantilla wrote 1,003 Medicare Part D claims for 271 patients. 44% of them were for generic drugs. CMS names the drug for 826 of them, across 23 drugs with 11 or more claims each, at $483,453 in total drug cost.

Matthew Mantilla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Matthew Mantilla as offering telehealth.

CMS Open Payments shows 21 general payments to Matthew Mantilla from 10 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $128.